Well, duh: weight loss drugs breaking employers' banks (WSJ)
Posted by Potomac on May 24, 2026, 7:02:46
Employers and government officials are surprised. What did they think would happen? Especially when a town already has budget problems. From WSJ:
Officials in Belchertown, Mass., were saving up to fix their broken roads and aging buildings last year when they were hit with a surprise $911,000 invoice.
The bill came from the Hampshire County Group Insurance Trust, which manages healthcare for dozens of New England towns, school districts and other public entities. The trust was struggling to control rising costs that had sucked up its reserves, including a new, surprising culprit: the snowballing cost of GLP-1 weight-loss drugs.
The trust was nearing insolvency, and towns would need to pay up to keep it afloat.... Officials had to draw from the town’s long-term savings and make departmental cuts, including school-budget reductions, to pay off the bill....
Many public employers started covering weight-loss medications for teachers, firefighters and police officers a few years ago when the blockbuster drugs hit the market, following the lead of big companies. Far more employees were prescribed the drugs than expected.
Cities and towns are now racing to control surging healthcare costs, and many blame the increasingly ubiquitous drugs for contributing to a budget squeeze.
Some towns are gearing up to strip coverage of GLP-1s for weight loss when their fiscal years end next month. Other localities have decided that the costs of the drugs are worth their potential health benefits. And some are stuck paying for the drugs until they can renegotiate contracts with employees....
It could take years for employers to determine how the drugs are affecting their healthcare systems, but towns and states need to make coverage decisions right now. The result: debates in council chambers and school committees on the pros and cons of a specific class of medications, an unusual topic for city managers.
Many states, cities and private employers have stripped coverage of GLP-1s for weight loss from their plans, or imposed limits on who is eligible. The Peterson-KFF Health System Tracker estimated this past fall that one-fifth of companies with 200 or more workers cover weight-loss drugs in their largest health plans....
In Massachusetts, members of the Hampshire County trust determined that the financial burdens were unsustainable. They voted to strip coverage of the GLP-1s for weight loss. In a statement, the trust’s executive committee said that in the first nine months of 2025, weight-loss drugs accounted for 30% of the group’s pharmacy spending but less than 3% of its membership. The trust hired a consulting group to assess the damage and plan a turnaround, and an executive stepped down....
just stripped coverage for GLP-1s for weight loss only. It cost the SD close to $750k this year alone.
Previous Message
Employers and government officials are surprised. What did they think would happen? Especially when a town already has budget problems. From WSJ:
Officials in Belchertown, Mass., were saving up to fix their broken roads and aging buildings last year when they were hit with a surprise $911,000 invoice.
The bill came from the Hampshire County Group Insurance Trust, which manages healthcare for dozens of New England towns, school districts and other public entities. The trust was struggling to control rising costs that had sucked up its reserves, including a new, surprising culprit: the snowballing cost of GLP-1 weight-loss drugs.
The trust was nearing insolvency, and towns would need to pay up to keep it afloat.... Officials had to draw from the town’s long-term savings and make departmental cuts, including school-budget reductions, to pay off the bill....
Many public employers started covering weight-loss medications for teachers, firefighters and police officers a few years ago when the blockbuster drugs hit the market, following the lead of big companies. Far more employees were prescribed the drugs than expected.
Cities and towns are now racing to control surging healthcare costs, and many blame the increasingly ubiquitous drugs for contributing to a budget squeeze.
Some towns are gearing up to strip coverage of GLP-1s for weight loss when their fiscal years end next month. Other localities have decided that the costs of the drugs are worth their potential health benefits. And some are stuck paying for the drugs until they can renegotiate contracts with employees....
It could take years for employers to determine how the drugs are affecting their healthcare systems, but towns and states need to make coverage decisions right now. The result: debates in council chambers and school committees on the pros and cons of a specific class of medications, an unusual topic for city managers.
Many states, cities and private employers have stripped coverage of GLP-1s for weight loss from their plans, or imposed limits on who is eligible. The Peterson-KFF Health System Tracker estimated this past fall that one-fifth of companies with 200 or more workers cover weight-loss drugs in their largest health plans....
In Massachusetts, members of the Hampshire County trust determined that the financial burdens were unsustainable. They voted to strip coverage of the GLP-1s for weight loss. In a statement, the trust’s executive committee said that in the first nine months of 2025, weight-loss drugs accounted for 30% of the group’s pharmacy spending but less than 3% of its membership. The trust hired a consulting group to assess the damage and plan a turnaround, and an executive stepped down....
Employers and government officials are surprised. What did they think would happen? Especially when a town already has budget problems. From WSJ:
Officials in Belchertown, Mass., were saving up to fix their broken roads and aging buildings last year when they were hit with a surprise $911,000 invoice.
The bill came from the Hampshire County Group Insurance Trust, which manages healthcare for dozens of New England towns, school districts and other public entities. The trust was struggling to control rising costs that had sucked up its reserves, including a new, surprising culprit: the snowballing cost of GLP-1 weight-loss drugs.
The trust was nearing insolvency, and towns would need to pay up to keep it afloat.... Officials had to draw from the town’s long-term savings and make departmental cuts, including school-budget reductions, to pay off the bill....
Many public employers started covering weight-loss medications for teachers, firefighters and police officers a few years ago when the blockbuster drugs hit the market, following the lead of big companies. Far more employees were prescribed the drugs than expected.
Cities and towns are now racing to control surging healthcare costs, and many blame the increasingly ubiquitous drugs for contributing to a budget squeeze.
Some towns are gearing up to strip coverage of GLP-1s for weight loss when their fiscal years end next month. Other localities have decided that the costs of the drugs are worth their potential health benefits. And some are stuck paying for the drugs until they can renegotiate contracts with employees....
It could take years for employers to determine how the drugs are affecting their healthcare systems, but towns and states need to make coverage decisions right now. The result: debates in council chambers and school committees on the pros and cons of a specific class of medications, an unusual topic for city managers.
Many states, cities and private employers have stripped coverage of GLP-1s for weight loss from their plans, or imposed limits on who is eligible. The Peterson-KFF Health System Tracker estimated this past fall that one-fifth of companies with 200 or more workers cover weight-loss drugs in their largest health plans....
In Massachusetts, members of the Hampshire County trust determined that the financial burdens were unsustainable. They voted to strip coverage of the GLP-1s for weight loss. In a statement, the trust’s executive committee said that in the first nine months of 2025, weight-loss drugs accounted for 30% of the group’s pharmacy spending but less than 3% of its membership. The trust hired a consulting group to assess the damage and plan a turnaround, and an executive stepped down....